ARTICLE | Company News
Pharmagene,Taisho in preclinical deal
March 9, 2001 8:00 AM UTC
Pharmagene (LSE:PGN) will use human hepatocytes to investigate gene expression profiling to improve toxicity prediction for compounds provided by Taisho (Tokyo, Japan). PGN also will use human tissue ...